missing translation for 'onlineSavingsMsg'
Learn More

AZD-8055, MedChemExpress

Artikelnummer. 16460317
Encompass_Preferred
Change view
Click to view available options
Menge:
10 mg
50 mg
100 mg
200 mg
Unit Size:
200 Milligramm
50 Milligramm
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Menge unitSize
16460317 50 mg 50 Milligramm
16454976 100 mg -
16403968 10 mg -
16440986 200 mg 200 Milligramm
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
This item is not returnable. View return policy
Product Code. 16460317 Supplier Medchem Express Supplier No. HY10422

Bitte Sie sich an, um diesen Artikel zu kaufen. Sie benötigen ein Web-Konto? Registrieren Sie sich noch heute!

This item is not returnable. View return policy

MedChemExpress AZD-8055 is a potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM. AZD-8055 inhibits both mTORC1 and mTORC2.

AZD-8055 is a potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM. AZD-8055 inhibits both mTORC1 and mTORC2.

Specifications

Chemischer Name oder Material AZD-8055
CAS 1009298-09-2
Farbe Yellow
Hinweise zur Reinheitsqualität Research
Summenformel C25H31N5O4
Menge 50 mg
Löslichkeitsinformationen DMSO : 33.33 mg/mL (71.59 mM; Need ultrasonic)
SMILES OCC1=CC(C2=NC3=NC(N4CCOC[C@@H]4C)=NC(N5[C@@H](C)COCC5)=C3C=C2)=CC=C1OC
Molekulargewicht (g/mol) 465.54
Formelmasse 465.54
Reinheit (%) 95.0%
Güte Research
Physikalische Form Solid
Zur Verwendung mit (Anwendung) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.